期刊文献+

心脏型肌球蛋白结合蛋白C基因13261 G>A突变导致肥厚型心肌病的临床表型分析 被引量:5

Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261G> A mutation in cardiac myosin-binding protein C gene
原文传递
导出
摘要 目的研究中国人肥厚型心肌病致病基因,分析基因型与临床表型的关系。方法在一肥厚型心肌病家系中进行心脏型肌球蛋白结合蛋白 C 基因(MYBPC3)和β-肌球蛋白重链基因(MYH7)突变筛查,利用聚合酶链反应(PCR)扩增其功能区的外显子片段,双脱氧末段终止法测序。家系调查资料包括临床表现、体格检查、心脏超声和心电图。结果在该家系27例有血缘关系的研究对象中9例携带 MYBPC3 13261 G>A(G758D)突变,正常对照组同一位置未见异常。该突变位点是 MYBPC3基因第23号外显子的甘氨酸突变为天冬氨酸,其中2例携带者发病,一例表现为心室扩大,左室射血分数减低等扩张型心肌病样表现,伴室间隔不对称肥厚,厚度为14 mm,另外一例患者为典型的肥厚型心肌病表现。MYH7基因未发现突变。结论 MYBPC3基因13261 G>A 突变是该肥厚型心肌病家系的致病突变,其外显率为22%,其中一例患者表现为肥厚型心肌病的扩张相,MYBPC3基因 G758D 突变可能是肥厚型心肌病进展为扩张型心肌病样改变的原因之一。对临床表现为扩张型心肌病的患者进行家族史调查及基因检查十分必要。 Objective To study the disease-causing gene mutation in Chinese patients with hypertrophic cardiomyopathy (HCM) and to analyze the genotype and phenotype correlation. Methods One family (n = 27 ) affected with HCM were chosen for the study. The full encoding exons and flanking sequences of β-myosin heavy chain gene (MYH7) and cardiac myosin-binding protein C gene (MYBPC3) were amplified with PCR and the products were sequenced. The clinical data including symptom, physical, echocardiography and electrocardiography examinations were collected. Results We identified a 13261 G 〉 A mutation, which causes a misseuse mutation (G758D) in exon 23 of MYBPC3 in 9 family members. One mutation carrier suffered from dilated cardiomyopathy (DCM) with asymmetric interventricular septal hypertrophy ( 14 mm). Another mutation carrier was diagnosed as HCM. Conclusions The 13261 G 〉 A mutation is associated with a DCM-like HCM and HCM phenotype in this Chinese family affected with HCM.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2007年第1期17-20,共4页 Chinese Journal of Cardiology
基金 北京市自然科学基金委员会资助2004年重大项目(704001)
关键词 心肌病 肥厚性 突变 表型 Cardiomyopathy,hypertrophic Mutation Phenotype
  • 相关文献

参考文献14

  • 1Seidman JG,Seidman C.The genetic basis for cardiomyopathy:from mutation identification to mechanistic paradigms.Cell,2001,104(4):557-567.
  • 2Zou Y,Song L,Wang Z,et al.Prevalence of idiopathic hypertrophic cardiomyopathy in China:a population-based echocardiographic analysis of 8080 adults.Am J Med,2004,116(1):14-18.
  • 3Song L,Zou Y,Wang J,et al.Mutations profile in Chinese patients with hypertrophic cardiomyopathy.Clin Chim Acta,2005,351(1-2):209-216.
  • 4Spirito P,Bellone P.Natural history of hypertrophic cardiomyopathy.Br Heart J,1994,72(6 Suppl):S10-S12.
  • 5Maron BJ,Anan TJ,Roberts WC.Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.Circulation,1981,63(4):882-894.
  • 6Maron BJ,McKenna WJ,Danielson GK,et al.American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy.A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.Eur Heart J,2003,24(21):1965-1991.
  • 7Maron BJ.Hypertrophic cardiomyopathy:a systematic review.JAMA,2002,287(10):1308-1320.
  • 8Hina K,Kusachi S,Iwasaki K,et al.Use of serum creatine kinase MM isoforms for predicting the progression of left ventricular dilation in patients with hypertrophic cardiomyopathy.Jpn Circ J,1997,61(4):315-322.
  • 9Shimizu M,Ino H,Yamaguchi M,et al.Autopsy findings in siblings with hypertrophic cardiomyopathy caused by Arg92Trp mutation in the cardiac troponin T gene showing dilated cardiomyopathy-like features.Clin Cardiol,2003,26(11):536-539.
  • 10Carrier L,Bonne G,Bahrend E,et al.Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.Circ Res,1997,80(3):427-434.

二级参考文献14

  • 1陆林,于金德,况少青,何汝敏,龚兰生.血管紧张素转化酶基因缺失多态性与肥厚型心肌病的关系[J].临床心血管病杂志,1996,12(3):137-139. 被引量:7
  • 2Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2001, 33:655-670.
  • 3Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 2001, 104:557-567.
  • 4Bonne G, Carrier L, Richard P, et al. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Circ Res, 1998, 83:580-593.
  • 5Rayment I, Rypniewski RW, Schmidt-Base K, et al. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science, 1993, 261:50-58.
  • 6Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest, 1994, 93:280-285.
  • 7Niimura H, Bachinski LL, Sangwatanaro JS, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med, 1998, 338:1248-1257.
  • 8Ortlepp JR, Vosberg HP, Reith S, et al. Genetic polymorphisms in the renin- angiotensin -aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart, 2002, 87:270-275.
  • 9Futterman LG, Myerburg R. Sudden death in athletes: an update. Sports Med, 1998, 26:335-350.
  • 10Marian AJ. Sudden cardiac death in patients with hypertrophic cardiomyopathy: from bench to bedside with an emphasis on genetic markers. Clin Cardiol, 1995, 18:189-198.

共引文献26

同被引文献56

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部